octreoscan 111 mbq/ml, kit for radiopharmaceutical preparation
curium netherlands b.v. - indium (111 in) chloride solution; pentetreotide - kit for radiopharmaceutical preparation - 111 megabecquerel(s)/millilitre - indium (111in) pentetic acid
octreoscan injection composite pack with needle
landauer radiopharmaceuticals pty ltd - indium (111in) chloride,pentetreotide -
octreoscan 111 mbq/ml kit for radiopharm. prep. i.v. vial
mallinckrodt belgium s.p.r.l.-b.v.b.a. - pentetreotide 10 µg; indium (111 in) chloride 122 mbq/1,1 ml - kit for radiopharmaceutical preparation - 111 mbq/ml - indium (in-111) chloride 111 mbq/ml; pentetreotide 10 µg - indium (111in) pentetreotide
octreoscan- indium in -111 pentetreotide kit
curium us llc - indium in-111 pentetreotide (unii: m312jj6z32) (indium in-111 pentetreotide - unii:m312jj6z32) - pentetreotide 10 ug in 1 ml - octreoscan, after radiolabeling, is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors. none known.
high purity indium chloride in 111 sterile solution
curium canada inc - indium in 111 chloride - solution - 10mci - indium in 111 chloride 10mci - radioactive agents
octreoscan
mallinckrodt australia pty ltd - indium(111in) chloride; pentetreotide -
indium in 111 chloride solution
curium us llc - indium chloride in-111 (unii: 58td96h03i) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 10 mci in 1 ml - indium in 111 chloride sterile solution is indicated for radiolabeling prostascint preparations used for in vivo diagnostic imaging procedures. it is also indicated for radiolabeling zevalin preparations used for radioimmunotherapy procedures. please refer to the package insert for prostascint or zevalin for information on the final drug product. please refer to the package insert for prostascint or zevalin for this information on the final drug product.
indium dtpa in 111- indium in-111 pentetate disodium solution
medi-physics, inc. dba ge healthcare - indium in-111 pentetate disodium (unii: 7uit3zgc8e) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 mci in 1 ml - pentetate indium disodium in 111 is recommended for use in radionuclide cisternography. none known.
indium in 111 oxyquinoline- indium in-111 oxyquinoline solution
medi-physics inc. dba ge healthcare. - indium in-111 oxyquinoline (unii: lgx9ol562t) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 ug in 1 ml - indium in 111 oxyquinoline solution is indicated for radiolabeling autologous leukocytes. indium in 111 oxyquinoline labeled leukocytes may be used as an adjunct in the detection of inflammatory processes to which leukocytes migrate, such as those associated with abscesses or other infection, following reinjection and detection by appropriate imaging procedures. the degree of accuracy may vary with labeling techniques and with the size, location and nature of the inflammatory process. indium in 111 oxyquinoline labeled leukocyte imaging is not the preferred technique for the initial evaluation of patients with a high clinical probability of an abscess in a known location. ultrasound or computed tomography may provide a better anatomical delineation of the infectious process and information may be obtained more quickly than with labeled leukocytes. if localization by these techniques is successful, labeled leukocytes should not be used as a confirmatory procedure. if localization or diagnosis by these methods fails or is ambiguous, indium in 111 oxyquinoline labeled leukocyte imaging may be appropriate. none known.
octreoscan solution
curium canada inc - indium in 111 chloride; pentetreotide - solution - 111mbq; 10mcg - indium in 111 chloride 111mbq; pentetreotide 10mcg - roentgenography